Cva Family Office, LLC Argenx Se Transaction History
Cva Family Office, LLC
- $550 Million
- Q2 2024
A detailed history of Cva Family Office, LLC transactions in Argenx Se stock. As of the latest transaction made, Cva Family Office, LLC holds 3 shares of ARGX stock, worth $1,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 2
50.0%
Holding current value
$1,458
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARGX
# of Institutions
358Shares Held
31.3MCall Options Held
212KPut Options Held
210K-
Price T Rowe Associates Inc Baltimore, MD5.5MShares$2.68 Billion0.27% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.19MShares$1.55 Billion1.93% of portfolio
-
Janus Henderson Group PLC London, X02.22MShares$1.08 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.12MShares$1.03 Billion0.51% of portfolio
-
Capital World Investors Los Angeles, CA1.86MShares$907 Million0.13% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $26.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...